RHINOSTOP SPRAY NASAL 0.1% 15ML

Active substance

Xylometazoline

Composition

Active ingredient: Xylometazoline

pharmachologic effect

Xylometazoline belongs to the group of local vasoconstrictor agents (decongestants) with alpha adrenomimetic activity, causes constriction of the blood vessels of the nasal mucosa, thus eliminating edema and hyperemia of the nasal mucosa, restores the nasal passages, and eases nasal breathing.
The effect of the drug occurs within a few minutes after its use and lasts up to 10 hours.

Pharmacokinetics

When applied topically, the drug is practically not absorbed, therefore its concentration in the blood plasma is very low (it is not determined by modern analytical methods).

Indications

Applied with acute respiratory diseases with symptoms of rhinitis (rhinitis), acute allergic rhinitis, sinusitis, with otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa), rhinitis with allergies and colds.
Preparing the patient for diagnostic manipulations in the nasal passages.

Contraindications

Hypersensitivity to xylometazoline and other components of the drug, arterial hypertension, tachycardia, pronounced atherosclerosis, glaucoma, atrophic rhinitis, surgical procedures on the meninges (in history), conditions after transsphenoidal hypophysectomy, childhood (up to 2 years for 0.05%,% 0% for%),% for% 0.05% for% 0%% for% 0% for adrenal glandular hypophysectomy., up to 6 years for 0.1% spray), pregnancy.
Do not use in the treatment of monoamine oxidase inhibitors and tricyclic antidepressants (including a period of 14 days after their withdrawal).

Side effects

With frequent and / or long-term use: irritation of the mucous membranes, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.

Rarely: swelling of the nasal mucosa (usually with prolonged use), heartbeat, heart rhythm disturbances, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.

With prolonged use in high doses: depressive state.

How to take, the course of administration and dosage

Apply topically for 7-14 days. The dose depends on the dosage form used and the age of the patient.

Release form

nasal spray

Storage conditions

In a dry, dark place at a temperature of no higher than 25 ° C.